UNIGE document Scientific Article
previous document  unige:19608  next document
add to browser collection

EZH2 is essential for glioblastoma cancer stem cell maintenance

Suva, Mario-Luca
Riggi, Nicolo
Janiszewska, Michalina
Provero, Paolo
Stehle, Jean-Christophe
Baumer, Karine
Le Bitoux, Marie-Aude
show hidden authors show all authors [1 - 13]
Published in Cancer Research. 2009, vol. 69, no. 24, p. 9211-9218
Abstract Overexpression of the polycomb group protein enhancer of zeste homologue 2 (EZH2) occurs in diverse malignancies, including prostate cancer, breast cancer, and glioblastoma multiforme (GBM). Based on its ability to modulate transcription of key genes implicated in cell cycle control, DNA repair, and cell differentiation, EZH2 is believed to play a crucial role in tissue-specific stem cell maintenance and tumor development. Here, we show that targeted pharmacologic disruption of EZH2 by the S-adenosylhomocysteine hydrolase inhibitor 3-deazaneplanocin A (DZNep), or its specific downregulation by short hairpin RNA (shRNA), strongly impairs GBM cancer stem cell (CSC) self-renewal in vitro and tumor-initiating capacity in vivo. Using genome-wide expression analysis of DZNep-treated GBM CSCs, we found the expression of c-myc, recently reported to be essential for GBM CSCs, to be strongly repressed upon EZH2 depletion. Specific shRNA-mediated downregulation of EZH2 in combination with chromatin immunoprecipitation experiments revealed that c-myc is a direct target of EZH2 in GBM CSCs. Taken together, our observations provide evidence that direct transcriptional regulation of c-myc by EZH2 may constitute a novel mechanism underlying GBM CSC maintenance and suggest that EZH2 may be a valuable new therapeutic target for GBM management.
Keywords AnimalsCell Line, TumorDNA-Binding Proteins/antagonists & inhibitors/*biosynthesis/geneticsDown-RegulationGene Expression ProfilingGene Expression Regulation, NeoplasticGenes, mycGlioblastoma/genetics/metabolism/*pathologyHumansMiceMice, Inbred NODMice, SCIDNeoplastic Stem Cells/metabolism/*pathologyRNA, Small Interfering/geneticsTranscription Factors/antagonists & inhibitors/*biosynthesis/genetics
PMID: 19934320
Full text
(ISO format)
SUVA, Mario-Luca et al. EZH2 is essential for glioblastoma cancer stem cell maintenance. In: Cancer Research, 2009, vol. 69, n° 24, p. 9211-9218. doi: 10.1158/0008-5472.CAN-09-1622 https://archive-ouverte.unige.ch/unige:19608

394 hits

0 download


Deposited on : 2012-04-23

Export document
Format :
Citation style :